Photo: thehindu.com
Jubilant Pharmova Expands U.S. Operations with $132M Sterile Injectable Line
Jubilant Pharmovas subsidiary, Jubilant HollisterStier LLC, has unveiled a $132 million sterile injectable line in Spokane, Washington, enhancing its U.S. manufacturing capabilities significantly.
- The new sterile fill and finish line, launched by Jubilant HollisterStier LLC, marks a $132 million investment in Spokane, Washington, focusing on sterile injectables for global pharma clients.
- With the addition of this third line, the subsidiary aims to double its total sterile injectable manufacturing capacity at the Spokane, Washington facility within the coming months.
- Jubilant HollisterStier LLC specializes in injection (medicine) and is committed to maintaining high standards of sterilization (microbiology) in their production processes.
Why It Matters
This expansion reflects a growing demand for sterile injectables in the pharmaceutical industry, positioning Jubilant Pharmova as a key player in the U.S. market and enhancing its capacity to meet global healthcare needs.